ArticleBMC cancer2026

Therapeutic outcomes of PD-1 blockade-related regimens versus docetaxel in previously immunotherapy-treated advanced non-small cell lung cancer: a retrospective, exploratory study.

Ting-Ting Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.